Disc Medicine (IRON)
Disc Medicine on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
Short interest in Disc Medicine (IRON) was 6.9 million shares at the 30 October 2026 settlement, down 8.0% from the 15 October 2026 settlement, with days to cover at 3.2. In the last 90 days Disc Medicine insiders reported 28 open-market sales and no purchases, net sales of $11.9 million. The largest was a sale of 26,542 shares worth $2.1 million by Bitterman Kevin (Director) on 2 September 2026. The next earnings report for Disc Medicine is estimated for 11 January 2027.
6.9M
Short interest
settlement 2026-10-30
3.2
Days to cover
-7.5 days vs prior
52.9%
Short share of volume
2026-11-20
12,952
Fails to deliver
settlement 2026-10-30
Mon 11 Jan
Next earnings
estimated date
-$11.9M
Insider flow, 90 days
0 buys, 28 sells
As of 2026-11-20.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 October 2026, short interest in IRON is 6,862,594 shares, down 407,826 shares over the last month. Over the last 48 readings it ranged from 1,628,477 shares (29 November 2024) to 7,457,523 shares (15 October 2026). At the reported average volume of 2.2M shares a day that is 3.2 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/iron" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-30 | 6,862,594 | -8.0% | 2,159,377 | 3.18 |
| 2026-10-15 | 7,457,523 | +2.6% | 701,301 | 10.63 |
| 2026-09-30 | 7,270,420 | +0.9% | 568,317 | 12.79 |
| 2026-09-15 | 7,207,702 | -2.1% | 528,932 | 13.63 |
| 2026-08-31 | 7,365,002 | +0.3% | 442,810 | 16.63 |
| 2026-08-14 | 7,342,568 | -0.7% | 295,889 | 24.82 |
| 2026-07-31 | 7,394,606 | +1.4% | 353,401 | 20.92 |
| 2026-07-15 | 7,290,442 | +14.6% | 675,783 | 10.79 |
| 2026-06-30 | 6,363,314 | +5.9% | 995,180 | 6.39 |
| 2026-06-15 | 6,010,116 | +0.2% | 427,108 | 14.07 |
| 2026-05-29 | 5,999,027 | +5.8% | 411,197 | 14.59 |
| 2026-05-15 | 5,668,145 | +2.3% | 537,289 | 10.55 |
| 2026-04-30 | 5,538,727 | +5.7% | 355,541 | 15.58 |
| 2026-04-15 | 5,241,636 | -4.0% | 421,825 | 12.43 |
| 2026-03-31 | 5,460,074 | +21.4% | 574,461 | 9.50 |
| 2026-03-13 | 4,496,970 | +5.3% | 581,989 | 7.73 |
| 2026-02-27 | 4,269,919 | +25.1% | 1,046,554 | 4.08 |
| 2026-02-13 | 3,412,711 | -16.8% | 874,142 | 3.90 |
| 2026-01-30 | 4,100,690 | -4.2% | 473,685 | 8.66 |
| 2026-01-15 | 4,281,868 | +13.0% | 563,635 | 7.60 |
| 2025-12-31 | 3,790,158 | +53.8% | 785,510 | 4.83 |
| 2025-12-15 | 2,464,343 | -4.7% | 476,471 | 5.17 |
| 2025-11-28 | 2,586,932 | -14.2% | 677,188 | 3.82 |
| 2025-11-14 | 3,015,866 | +5.2% | 430,359 | 7.01 |
| 2025-10-31 | 2,867,219 | +6.4% | 716,500 | 4.00 |
| 2025-10-15 | 2,693,868 | +2.1% | 398,750 | 6.76 |
| 2025-09-30 | 2,638,649 | +17.9% | 376,059 | 7.02 |
| 2025-09-15 | 2,237,016 | +6.4% | 338,197 | 6.61 |
| 2025-08-29 | 2,102,467 | -13.6% | 231,941 | 9.06 |
| 2025-08-15 | 2,431,864 | +7.7% | 373,522 | 6.51 |
| 2025-07-31 | 2,259,068 | -20.2% | 395,045 | 5.72 |
| 2025-07-15 | 2,831,428 | -7.7% | 280,507 | 10.09 |
| 2025-06-30 | 3,068,367 | -4.3% | 428,129 | 7.17 |
| 2025-06-13 | 3,204,802 | +3.5% | 428,289 | 7.48 |
| 2025-05-30 | 3,096,277 | -4.2% | 305,092 | 10.15 |
| 2025-05-15 | 3,231,435 | +0.6% | 395,087 | 8.18 |
| 2025-04-30 | 3,212,366 | +17.5% | 353,455 | 9.09 |
| 2025-04-15 | 2,733,628 | +13.1% | 725,896 | 3.77 |
| 2025-03-31 | 2,417,318 | +8.1% | 397,369 | 6.08 |
| 2025-03-14 | 2,235,716 | -3.7% | 338,134 | 6.61 |
| 2025-02-28 | 2,321,289 | -6.4% | 346,694 | 6.70 |
| 2025-02-14 | 2,478,863 | +14.0% | 284,507 | 8.71 |
| 2025-01-31 | 2,174,591 | +6.4% | 555,961 | 3.91 |
| 2025-01-15 | 2,043,718 | +15.4% | 345,840 | 5.91 |
| 2024-12-31 | 1,770,940 | +6.7% | 207,148 | 8.55 |
| 2024-12-13 | 1,660,569 | +2.0% | 238,975 | 6.95 |
| 2024-11-29 | 1,628,477 | -0.9% | 279,321 | 5.83 |
| 2024-11-15 | 1,643,231 | +1.0% | 544,195 | 3.02 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 20 November 2026, the short share of IRON volume is 52.9%, down 5.1 points over the last five sessions. Over the last 30 readings it ranged from 27.0% (6 November 2026) to 80.8% (16 October 2026). The latest reading is 3.9 points above the 30-session average of 49.0%, on 206K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-20 | 109K | 206K | 52.9% | 1 |
| 2026-11-19 | 69K | 177K | 39.1% | 1 |
| 2026-11-18 | 134K | 281K | 47.5% | 0 |
| 2026-11-17 | 82K | 167K | 49.2% | 0 |
| 2026-11-16 | 167K | 335K | 49.7% | 10 |
| 2026-11-13 | 140K | 241K | 58.1% | 0 |
| 2026-11-12 | 205K | 315K | 65.2% | 0 |
| 2026-11-11 | 100K | 186K | 53.7% | 0 |
| 2026-11-10 | 324K | 875K | 37.0% | 2,366 |
| 2026-11-09 | 101K | 300K | 33.6% | 0 |
| 2026-11-06 | 74K | 274K | 27.0% | 0 |
| 2026-11-05 | 107K | 293K | 36.7% | 0 |
| 2026-11-04 | 81K | 232K | 34.8% | 20 |
| 2026-11-03 | 121K | 269K | 44.9% | 0 |
| 2026-11-02 | 65K | 165K | 39.6% | 29 |
| 2026-10-30 | 116K | 214K | 54.1% | 5 |
| 2026-10-29 | 98K | 220K | 44.4% | 0 |
| 2026-10-28 | 140K | 281K | 49.6% | 796 |
| 2026-10-27 | 206K | 514K | 40.1% | 1,000 |
| 2026-10-26 | 138K | 320K | 43.2% | 1,500 |
| 2026-10-23 | 177K | 399K | 44.5% | 1,400 |
| 2026-10-22 | 261K | 505K | 51.7% | 49 |
| 2026-10-21 | 721K | 1.8M | 40.0% | 0 |
| 2026-10-20 | 397K | 967K | 41.1% | 238 |
| 2026-10-19 | 1.8M | 3.4M | 54.1% | 5,868 |
| 2026-10-16 | 160K | 198K | 80.8% | 0 |
| 2026-10-15 | 130K | 240K | 54.1% | 35 |
| 2026-10-14 | 103K | 159K | 64.5% | 0 |
| 2026-10-13 | 175K | 229K | 76.3% | 0 |
| 2026-10-12 | 131K | 204K | 64.2% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 30 October 2026, the fails-to-deliver balance in IRON is 12,952 shares, up 12,652 shares over the last settlement date. Over the last 30 readings it ranged from 7 shares (22 May 2026) to 256,969 shares (2 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-30 | 12,952 | $82.84 | $1.1M |
| 2026-10-28 | 300 | $79.90 | $24K |
| 2026-10-22 | 68 | $76.00 | $5K |
| 2026-10-21 | 541 | $79.48 | $43K |
| 2026-10-20 | 20,075 | $78.93 | $1.6M |
| 2026-10-15 | 7 | $55.74 | $390 |
| 2026-10-13 | 643 | $60.48 | $39K |
| 2026-09-14 | 11,956 | $70.06 | $838K |
| 2026-08-21 | 48 | $78.84 | $4K |
| 2026-08-14 | 498 | $80.01 | $40K |
| 2026-08-11 | 845 | $78.28 | $66K |
| 2026-08-03 | 50 | $77.00 | $4K |
| 2026-07-31 | 14 | $79.21 | $1K |
| 2026-07-22 | 133 | $75.58 | $10K |
| 2026-07-21 | 564 | $74.38 | $42K |
| 2026-07-20 | 26 | $76.15 | $2K |
| 2026-07-02 | 256,969 | $74.95 | $19.3M |
| 2026-06-30 | 148 | $74.50 | $11K |
| 2026-06-29 | 17,517 | $74.78 | $1.3M |
| 2026-06-22 | 73,695 | $70.79 | $5.2M |
| 2026-06-15 | 1,326 | $67.99 | $90K |
| 2026-06-12 | 13 | $68.08 | $885 |
| 2026-06-10 | 1,390 | $68.34 | $95K |
| 2026-06-04 | 1,767 | $70.35 | $124K |
| 2026-06-03 | 63 | $68.00 | $4K |
| 2026-06-02 | 2,957 | $71.97 | $213K |
| 2026-05-28 | 1,675 | $69.76 | $117K |
| 2026-05-27 | 1,065 | $68.12 | $73K |
| 2026-05-26 | 1,449 | $66.82 | $97K |
| 2026-05-22 | 7 | $67.13 | $470 |
Insider trades
SEC Form 4, newest first. JSONInsiders at IRON reported 28 open-market sells worth $11.9M in the last 90 days and no open-market buys. Latest filing: Savage William Jacob (Chief Medical Officer) on 2026-11-10.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-11-10 | Savage William Jacob | Chief Medical Officer | Sell | 16K | $85.09 | $1.4M | 63K |
| 2026-10-21 | Bitterman Kevin | Director | Sell | 266 | $80.23 | $21K | 13K |
| 2026-10-21 | Bitterman Kevin | Director | Sell | 11K | $80.23 | $920K | 293K |
| 2026-10-21 | Bitterman Kevin | Director | Sell | 14K | $80.23 | $1.1M | 296K |
| 2026-10-20 | Bitterman Kevin | Director | Sell | 55 | $79.95 | $4K | 13K |
| 2026-10-20 | Bitterman Kevin | Director | Sell | 2K | $79.95 | $191K | 305K |
| 2026-10-20 | Bitterman Kevin | Director | Sell | 3K | $79.95 | $229K | 310K |
| 2026-10-19 | Bitterman Kevin | Director | Sell | 115 | $79.97 | $9K | 13K |
| 2026-10-19 | Bitterman Kevin | Director | Sell | 5K | $79.97 | $395K | 307K |
| 2026-10-19 | Bitterman Kevin | Director | Sell | 6K | $79.97 | $475K | 313K |
| 2026-09-15 | Quisel John D | Chief Executive Officer | Exercise or conversion | 36K | $1.01 | $36K | 262K |
| 2026-09-11 | Bitterman Kevin | Director | Exercise or conversion | 10K | $50.86 | $509K | 27K |
| 2026-09-11 | Bitterman Kevin | Director | Sell | 27K | $70.11 | $1.9M | 0 |
| 2026-09-11 | Bitterman Kevin | Director | Exercise or conversion | 10K | $38.85 | $389K | 17K |
| 2026-09-11 | Bitterman Kevin | Director | Exercise or conversion | 7K | $45.69 | $326K | 7K |
| 2026-09-04 | Bitterman Kevin | Director | Sell | 18 | $79.96 | $1K | 13K |
| 2026-09-04 | Bitterman Kevin | Director | Sell | 759 | $79.96 | $61K | 312K |
| 2026-09-04 | Bitterman Kevin | Director | Sell | 912 | $79.96 | $73K | 319K |
| 2026-09-03 | Bitterman Kevin | Director | Sell | 54 | $79.98 | $4K | 13K |
| 2026-09-03 | Bitterman Kevin | Director | Sell | 2K | $79.98 | $187K | 313K |
| 2026-09-03 | Bitterman Kevin | Director | Sell | 3K | $79.98 | $225K | 320K |
| 2026-09-02 | Bitterman Kevin | Director | Sell | 2 | $80.98 | $162 | 13K |
| 2026-09-02 | Bitterman Kevin | Director | Sell | 9 | $80.98 | $729 | 315K |
| 2026-09-02 | Bitterman Kevin | Director | Sell | 10 | $80.98 | $810 | 323K |
| 2026-09-02 | Bitterman Kevin | Director | Sell | 511 | $80.17 | $41K | 14K |
| 2026-09-02 | Bitterman Kevin | Director | Sell | 22K | $80.17 | $1.8M | 315K |
| 2026-09-02 | Bitterman Kevin | Director | Sell | 27K | $80.17 | $2.1M | 323K |
| 2026-09-01 | Bitterman Kevin | Director | Sell | 1 | $79.95 | $80 | 14K |
| 2026-09-01 | Bitterman Kevin | Director | Sell | 58 | $79.95 | $5K | 337K |
| 2026-09-01 | Bitterman Kevin | Director | Sell | 70 | $79.95 | $6K | 349K |
| 2026-08-25 | Yu Jonathan Yen-Wen | Chief Operating Officer | Sell | 9K | $83.12 | $731K | 54K |
| 2026-08-25 | Yu Jonathan Yen-Wen | Chief Operating Officer | Exercise or conversion | 9K | $13.50 | $119K | 63K |
| 2026-08-24 | Yu Jonathan Yen-Wen | Chief Operating Officer | Sell | 300 | $82.53 | $25K | 54K |
| 2026-08-24 | Yu Jonathan Yen-Wen | Chief Operating Officer | Exercise or conversion | 300 | $13.50 | $4K | 55K |
| 2026-08-17 | Quisel John D | Chief Executive Officer | Sell | 12K | $79.84 | $949K | 226K |
| 2026-08-17 | Quisel John D | Chief Executive Officer | Sell | 13K | $79.20 | $1.0M | 238K |
| 2026-08-17 | Quisel John D | Chief Executive Officer | Sell | 8K | $78.11 | $656K | 251K |
| 2026-08-17 | Quisel John D | Chief Executive Officer | Exercise or conversion | 33K | $13.50 | $446K | 259K |
| 2026-08-12 | Yu Jonathan Yen-Wen | Chief Operating Officer | Sell | 804 | $82.64 | $66K | 54K |
| 2026-08-12 | Yu Jonathan Yen-Wen | Chief Operating Officer | Exercise or conversion | 804 | $13.50 | $11K | 55K |
| 2026-08-06 | Khara Rahul | Chief Legal Officer | Sell | 5K | $80.00 | $400K | 52K |
| 2026-08-06 | Khara Rahul | Chief Legal Officer | Exercise or conversion | 5K | $14.69 | $73K | 57K |
| 2026-07-13 | Quisel John D | Chief Executive Officer | Sell | 6K | $76.05 | $487K | 226K |
| 2026-07-13 | Quisel John D | Chief Executive Officer | Sell | 17K | $74.95 | $1.3M | 232K |
| 2026-07-13 | Quisel John D | Chief Executive Officer | Sell | 10K | $74.27 | $721K | 249K |
| 2026-07-13 | Quisel John D | Chief Executive Officer | Exercise or conversion | 7K | $13.50 | $100K | 259K |
| 2026-07-13 | Quisel John D | Chief Executive Officer | Exercise or conversion | 26K | $9.86 | $252K | 252K |
| 2026-07-07 | Yu Jonathan Yen-Wen | Chief Operating Officer | Sell | 100 | $82.50 | $8K | 54K |
| 2026-07-07 | Yu Jonathan Yen-Wen | Chief Operating Officer | Exercise or conversion | 100 | $13.50 | $1K | 54K |
| 2026-06-29 | Khara Rahul | Chief Legal Officer | Sell | 2K | $75.00 | $124K | 52K |
| 2026-06-29 | Khara Rahul | Chief Legal Officer | Exercise or conversion | 2K | $14.69 | $24K | 54K |
| 2026-06-26 | Yu Jonathan Yen-Wen | Chief Operating Officer | Sell | 300 | $72.50 | $22K | 54K |
| 2026-06-26 | Yu Jonathan Yen-Wen | Chief Operating Officer | Exercise or conversion | 300 | $13.50 | $4K | 55K |
| 2026-06-26 | Khara Rahul | Chief Legal Officer | Exercise or conversion | 851 | $14.69 | $13K | 53K |
| 2026-06-26 | Khara Rahul | Chief Legal Officer | Sell | 851 | $75.00 | $64K | 52K |
| 2026-06-22 | Yu Jonathan Yen-Wen | Chief Operating Officer | Sell | 10K | $72.66 | $705K | 54K |
| 2026-06-22 | Yu Jonathan Yen-Wen | Chief Operating Officer | Exercise or conversion | 10K | $13.50 | $131K | 64K |
| 2026-06-18 | Quisel John D | Chief Executive Officer | Sell | 23K | $69.92 | $1.6M | 237K |
| 2026-06-18 | Quisel John D | Chief Executive Officer | Sell | 10K | $70.70 | $673K | 228K |
| 2026-06-18 | Quisel John D | Chief Executive Officer | Sell | 2K | $71.61 | $111K | 226K |
| 2026-06-18 | Quisel John D | Chief Executive Officer | Exercise or conversion | 34K | $9.86 | $335K | 260K |
| 2026-06-18 | Khara Rahul | Chief Legal Officer | Sell | 5K | $69.94 | $378K | 54K |
| 2026-06-18 | Khara Rahul | Chief Legal Officer | Sell | 2K | $70.73 | $113K | 53K |
| 2026-06-18 | Khara Rahul | Chief Legal Officer | Sell | 500 | $71.62 | $36K | 52K |
| 2026-06-18 | Khara Rahul | Chief Legal Officer | Exercise or conversion | 8K | $14.69 | $110K | 60K |
| 2026-06-16 | Yu Jonathan Yen-Wen | Chief Operating Officer | Sell | 12K | $68.76 | $801K | 61K |
| 2026-06-16 | Yu Jonathan Yen-Wen | Chief Operating Officer | Exercise or conversion | 5K | $9.86 | $52K | 60K |
| 2026-06-16 | Yu Jonathan Yen-Wen | Chief Operating Officer | Exercise or conversion | 13K | $9.86 | $132K | 73K |
| 2026-06-16 | Yu Jonathan Yen-Wen | Chief Operating Officer | Sell | 7K | $69.92 | $487K | 54K |
| 2026-04-14 | Franchi Jean M. | Chief Financial Officer | Sell | 6K | $69.24 | $433K | 64K |
| 2026-04-13 | Savage William Jacob | Chief Medical Officer | Sell | 2K | $66.81 | $147K | 79K |
| 2026-04-13 | Savage William Jacob | Chief Medical Officer | Sell | 4K | $66.12 | $233K | 82K |
| 2026-04-13 | Franchi Jean M. | Chief Financial Officer | Sell | 400 | $69.00 | $28K | 71K |
| 2026-03-02 | Savage William Jacob | Chief Medical Officer | Sell | 3K | $66.41 | $198K | 85K |
| 2026-03-02 | Savage William Jacob | Chief Medical Officer | Sell | 4K | $65.52 | $288K | 88K |
| 2026-02-25 | Franchi Jean M. | Chief Financial Officer | Sell | 353 | $69.06 | $24K | 71K |
| 2026-02-18 | Franchi Jean M. | Chief Financial Officer | Sell | 4K | $65.89 | $243K | 71K |
| 2026-02-18 | Franchi Jean M. | Chief Financial Officer | Sell | 3K | $65.01 | $221K | 75K |
| 2026-02-17 | Khara Rahul | Chief Legal Officer | Sell | 3K | $62.86 | $179K | 52K |
| 2026-02-17 | Stephenson Pamela | Chief Commercial Officer | Sell | 6K | $62.86 | $348K | 81K |
| 2026-02-17 | Savage William Jacob | Chief Medical Officer | Sell | 3K | $62.86 | $205K | 93K |
| 2026-02-17 | Yu Jonathan Yen-Wen | Chief Operating Officer | Sell | 3K | $62.86 | $203K | 54K |
| 2026-02-17 | Quisel John D | Chief Executive Officer | Sell | 13K | $62.86 | $834K | 226K |
| 2026-02-17 | Franchi Jean M. | Chief Financial Officer | Sell | 4K | $62.86 | $256K | 78K |
| 2026-02-10 | Khara Rahul | Chief Legal Officer | Grant | 17K | $0.00 | $0 | 55K |
| 2026-02-10 | Stephenson Pamela | Chief Commercial Officer | Grant | 17K | $0.00 | $0 | 87K |
| 2026-02-10 | Savage William Jacob | Chief Medical Officer | Grant | 17K | $0.00 | $0 | 96K |
| 2026-02-10 | Yu Jonathan Yen-Wen | Chief Operating Officer | Grant | 17K | $0.00 | $0 | 58K |
| 2026-02-10 | Franchi Jean M. | Chief Financial Officer | Grant | 19K | $0.00 | $0 | 82K |
| 2026-02-10 | Quisel John D | Chief Executive Officer | Grant | 55K | $0.00 | $0 | 239K |
| 2026-01-20 | Khara Rahul | Chief Legal Officer | Sell | 1K | $69.74 | $70K | 38K |
| 2026-01-20 | Khara Rahul | Chief Legal Officer | Exercise or conversion | 1K | $13.50 | $14K | 39K |
| 2026-01-02 | Khara Rahul | Chief Legal Officer | Sell | 1K | $79.27 | $92K | 38K |
| 2026-01-02 | Khara Rahul | Chief Legal Officer | Sell | 5K | $78.62 | $393K | 39K |
| 2026-01-02 | Khara Rahul | Chief Legal Officer | Sell | 350 | $77.67 | $27K | 44K |
| 2026-01-02 | Khara Rahul | Chief Legal Officer | Exercise or conversion | 7K | $13.50 | $88K | 44K |
| 2025-12-22 | Savage William Jacob | Chief Medical Officer | Exercise or conversion | 99 | $13.50 | $1K | 79K |
| 2025-12-22 | Savage William Jacob | Chief Medical Officer | Exercise or conversion | 219 | $9.86 | $2K | 79K |
| 2025-12-22 | Savage William Jacob | Chief Medical Officer | Exercise or conversion | 3K | $9.86 | $28K | 79K |
| 2025-12-19 | Quisel John D | Chief Executive Officer | Exercise or conversion | 12K | $1.01 | $12K | 184K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON50 Form 144 notices on file for IRON worth $54.5M at the prices reported; 2 in the last 90 days worth $3.2M. Latest: WILLIAM SAVAGE filed on 2026-11-10 to sell 16,035 shares ($1.3M) from 2026-11-10.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-11-10 | WILLIAM SAVAGEOfficer | 16K | $1.3M | 0.035% | 2026-11-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-11 | KEVIN J BITTERMANOfficer | 27K | $1.9M | 0.071% | 2026-09-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-17 | JOHN QUISELDirector, Officer | 33K | $2.6M | 0.086% | 2026-08-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-06 | RAHUL KHARAOfficer | 5K | $395K | 0.013% | 2026-08-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-13 | JOHN QUISELDirector, Officer | 33K | $2.5M | 0.086% | 2026-07-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-07 | JONATHAN YUOfficer | 10K | $770K | 0.026% | 2026-07-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-26 | RAHUL KHARAOfficer | 3K | $175K | 0.007% | 2026-06-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-22 | JONATHAN YUOfficer | 10K | $708K | 0.026% | 2026-06-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-18 | JOHN QUISELDirector, Officer | 34K | $2.4M | 0.089% | 2026-06-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-18 | RAHUL KHARAOfficer | 8K | $527K | 0.020% | 2026-06-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-16 | JONATHAN YUOfficer | 19K | $1.3M | 0.049% | 2026-06-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-13 | WILLIAM SAVAGEOfficer | 6K | $380K | 0.015% | 2026-04-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-02 | WILLIAM SAVAGEOfficer | 7K | $492K | 0.019% | 2026-03-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-25 | JEAN FRANCHIOfficer | 7K | $464K | 0.019% | 2026-02-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-18 | JEAN FRANCHIOfficer | 7K | $464K | 0.019% | 2026-02-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-17 | Khara RahulOfficer | 3K | $160K | 0.008% | 2026-02-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-17 | Stephenson PamelaOfficer | 6K | $309K | 0.015% | 2026-02-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-17 | Savage William JacobOfficer | 3K | $182K | 0.009% | 2026-02-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-17 | Yu Jonathan Yen-WenOfficer | 3K | $181K | 0.009% | 2026-02-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-17 | Franchi Jean M.Officer | 4K | $228K | 0.011% | 2026-02-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-17 | Quisel John DOfficer, Director | 13K | $742K | 0.035% | 2026-02-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-02 | RAHUL KHARAOfficer | 8K | $596K | 0.020% | 2026-01-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-17 | Atlas Venture Opportunity Fund II, LPShareholder | 213 | $19K | 0.001% | 2025-12-17 | Merrill Lynch |
| 2025-12-17 | Atlas Venture Opportunity Fund I, LPShareholder | 393 | $36K | 0.001% | 2025-12-17 | Merrill Lynch |
| 2025-12-17 | Atlas Venture Fund XII, LPShareholder | 148 | $14K | 0.000% | 2025-12-17 | Merrill Lynch |
| 2025-12-17 | Atlas Venture Fund X, LPShareholder | 818 | $75K | 0.002% | 2025-12-17 | Merrill Lynch |
| 2025-12-17 | AI DMI LLCAffiliate | 50 | $4K | 0.000% | 2025-12-17 | Tourmaline Partners, LLC |
| 2025-12-16 | Atlas Venture Opportunity Fund II, LPShareholder | 6K | $521K | 0.015% | 2025-12-16 | Merrill Lynch |
| 2025-12-16 | Atlas Venture Opportunity Fund II, L.P.Shareholder | 13K | $1.2M | 0.034% | 2025-12-16 | BTIG, LLC |
| 2025-12-16 | Atlas Venture Opportunity Fund I, LPShareholder | 11K | $1.0M | 0.029% | 2025-12-16 | Merrill Lynch |
| 2025-12-16 | Atlas Venture Opportunity Fund I, L.P.Shareholder | 25K | $2.3M | 0.066% | 2025-12-16 | BTIG, LLC |
| 2025-12-16 | Atlas Venture Fund XII, LPShareholder | 4K | $401K | 0.012% | 2025-12-16 | Merrill Lynch |
| 2025-12-16 | Atlas Venture Fund X, LPShareholder | 23K | $2.1M | 0.060% | 2025-12-16 | Merrill Lynch |
| 2025-12-16 | Atlas Venture Fund X, L.P.Shareholder | 52K | $4.8M | 0.138% | 2025-12-16 | BTIG, LLC |
| 2025-12-16 | Atlas Venture Associates XII, L.P.Shareholder | 10K | $915K | 0.026% | 2025-12-16 | BTIG, LLC |
| 2025-12-16 | AI DMI LLCAffiliate | 40K | $3.6M | 0.105% | 2025-12-16 | Tourmaline Partners, LLC |
| 2025-12-15 | WILLIAM SAVAGEOfficer | 13K | $1.2M | 0.035% | 2025-12-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-15 | KEVIN J BITTERMANOfficer | 7K | $643K | 0.019% | 2025-12-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-15 | Atlas Venture Opportunity Fund II, LPShareholder | 8K | $736K | 0.021% | 2025-12-15 | Merrill Lynch |
| 2025-12-15 | Atlas Venture Opportunity Fund II, L.P.Shareholder | 9K | $814K | 0.023% | 2025-12-15 | BTIG, LLC |
| 2025-12-15 | Atlas Venture Opportunity Fund I, LPShareholder | 15K | $1.4M | 0.041% | 2025-12-15 | Merrill Lynch |
| 2025-12-15 | Atlas Venture Opportunity Fund I, L.P.Shareholder | 17K | $1.6M | 0.046% | 2025-12-15 | BTIG, LLC |
| 2025-12-15 | Atlas Venture Fund XII, LPShareholder | 6K | $566K | 0.016% | 2025-12-15 | Merrill Lynch |
| 2025-12-15 | Atlas Venture Fund X, LPShareholder | 32K | $2.9M | 0.085% | 2025-12-15 | Merrill Lynch |
| 2025-12-15 | Atlas Venture Fund X, L.P.Shareholder | 37K | $3.4M | 0.098% | 2025-12-15 | BTIG, LLC |
| 2025-12-15 | Atlas Venture Associates XII, L.P.Shareholder | 7K | $629K | 0.018% | 2025-12-15 | BTIG, LLC |
| 2025-12-15 | AI DMI LLCAffiliate | 6K | $538K | 0.015% | 2025-12-15 | Tourmaline Partners, LLC |
| 2025-12-12 | Atlas Venture Opportunity Fund II, LPShareholder | 12K | $1.2M | 0.033% | 2025-12-12 | Merrill Lynch |
| 2025-12-12 | Atlas Venture Opportunity Fund I, LPShareholder | 24K | $2.2M | 0.063% | 2025-12-12 | Merrill Lynch |
| 2025-12-12 | Atlas Venture Fund XII, LPShareholder | 9K | $887K | 0.025% | 2025-12-12 | Merrill Lynch |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON10 holders report 5% or more of IRON in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is FMR LLC at 12.8% of the class (4,875,473 shares), filed 2026-08-06 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-26 | 13D/Ano. 7 | Access Industries Holdings LLCother entity | 2.9M | 6.6% | 2026-10-22 |
| 2026-10-26 | 13D/Ano. 7 | AI DMI LLCother entity | 2.9M | 6.6% | 2026-10-22 |
| 2026-10-26 | 13D/Ano. 7 | Access Industries Management, LLCother entity | 2.9M | 6.6% | 2026-10-22 |
| 2026-10-26 | 13D/Ano. 7 | Len Blavatnikindividual | 2.9M | 6.6% | 2026-10-22 |
| 2026-08-06 | 13G/Ano. 4 | FMR LLCparent holding company | 4.9M | 12.8% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 4 | Abigail P. Johnsonindividual | 4.9M | 12.8% | 2026-06-30 |
| 2026-01-07 | 13G | RA Capital Management, L.P.investment adviser, partnership | 2.2M | 5.9% | 2025-12-30 |
| 2026-01-07 | 13G | Peter Kolchinskyparent holding company, individual | 2.2M | 5.9% | 2025-12-30 |
| 2026-01-07 | 13G | Rajeev Shahparent holding company, individual | 2.2M | 5.9% | 2025-12-30 |
| 2026-01-07 | 13G | RA Capital Healthcare Fund, L.P.partnership | 2.2M | 5.9% | 2025-12-30 |
| 2025-12-17 | 13D/Ano. 5 | Atlas Venture Fund X, L.P.partnership | 813K | 2.2% | 2025-12-12 |
| 2025-12-17 | 13D/Ano. 5 | ATLAS VENTURE ASSOCIATES X, L.P.partnership | 813K | 2.2% | 2025-12-12 |
| 2025-12-17 | 13D/Ano. 5 | Atlas Venture Associates X, LLCother entity | 813K | 2.2% | 2025-12-12 |
| 2025-12-17 | 13D/Ano. 5 | Atlas Venture Associates Opportunity I, LLCother entity | 349K | 0.9% | 2025-12-12 |
| 2025-12-17 | 13D/Ano. 5 | Atlas Venture Associates Opportunity II, LPpartnership | 337K | 0.9% | 2025-12-12 |
| 2025-12-17 | 13D/Ano. 5 | Atlas Venture Associates Opportunity II, LLCother entity | 337K | 0.9% | 2025-12-12 |
| 2025-12-17 | 13D/Ano. 5 | Atlas Venture Opportunity Fund I, L.P.partnership | 349K | 0.9% | 2025-12-12 |
| 2025-12-17 | 13D/Ano. 5 | Atlas Venture Associates Opportunity I, L.P.partnership | 349K | 0.9% | 2025-12-12 |
| 2025-12-17 | 13D/Ano. 5 | Atlas Venture Opportunity Fund II, L.P.partnership | 337K | 0.9% | 2025-12-12 |
| 2025-12-17 | 13D/Ano. 5 | Atlas Venture Associates XII, L.P.partnership | 14K | 0.0% | 2025-12-12 |
| 2025-12-17 | 13D/Ano. 5 | Atlas Venture Fund XII, L.P.partnership | 14K | 0.0% | 2025-12-12 |
| 2025-12-17 | 13D/Ano. 5 | Atlas Venture Associates XII, LLCother entity | 14K | 0.0% | 2025-12-12 |
13F holders
Tracked managers holding IRON at their latest 13F. JSON5 of the 30 tracked managers held IRON at their latest 13F, $52.8M in total at quarter-end prices. Two Sigma Investments is the largest at $37.4M (0.0% of its portfolio) as of 2026-09-30. Over the prior quarter 2 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-09-30 | 571K | $37.4M | 0.03% | +434K |
| Citadel Advisors | 2026-09-30 | 131K | $8.6M | 0.00% | -78K |
| Millennium Management | 2026-09-30 | 53K | $3.5M | 0.00% | -53K |
| D. E. Shaw & Co. | 2026-09-30 | 43K | $2.8M | 0.00% | +37K |
| AQR Capital Management | 2026-09-30 | 9K | $563K | 0.00% | -1K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn FY 2025 it generated -$180.4M of operating cash flow. As of 2026-09-30, cash was $90.0M against $59.7M of debt.
- Cash
- $90.0M
- Debt
- $59.7M
- Equity
- $604.3M
- Total assets
- $699.5M
- Shares outstanding
- 45,540,842
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q3 FY 2026 | 2026-09-30 | n/a | -$59.5M | n/a | -1.53 |
| Q2 FY 2026 | 2026-06-30 | n/a | -$59.5M | n/a | -1.54 |
| Q1 FY 2026 | 2026-03-31 | n/a | -$63.5M | n/a | -1.65 |
| Q4 FY 2025derived | 2025-12-31 | n/a | -$60.5M | n/a | n/a |
| Q3 FY 2025 | 2025-09-30 | n/a | -$62.3M | n/a | -1.77 |
| Q2 FY 2025 | 2025-06-30 | n/a | -$55.2M | n/a | -1.58 |
| Q1 FY 2025 | 2025-03-31 | n/a | -$34.1M | n/a | -1.02 |
| Q4 FY 2024derived | 2024-12-31 | n/a | -$29.5M | n/a | n/a |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | n/a | -$212.2M | -$180.4M | $933K | n/a | n/a |
| FY 2024 | 2024-12-31 | n/a | -$109.4M | -$93.9M | $505K | n/a | n/a |
| FY 2023 | 2023-12-31 | n/a | -$76.4M | -$73.5M | $89K | n/a | n/a |
| FY 2022 | 2022-12-31 | n/a | -$46.8M | -$42.3M | $151K | n/a | n/a |
| FY 2021 | 2021-12-31 | n/a | -$36.0M | -$27.5M | $68K | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-09-30; shares outstanding as of 2026-10-29 from the cover page.
What this page is
Disc Medicine in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Disc Medicine (IRON), SEC CIK 1816736, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-20.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-30.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-11-10.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-26.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-09-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-09-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-11-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-11-10.JSON and CSV
- Company record
- EDGAR filing index for CIK 1816736Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
Datasets
Frequently Asked Questions
How much of IRON is sold short?
What is IRON's daily short volume?
Does IRON have fails to deliver?
Are IRON insiders buying or selling?
Have IRON insiders filed to sell?
Who owns 5% or more of IRON?
What did IRON report last quarter?
Which tracked 13F managers own IRON?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.